©The Author(s) 2026.
World J Gastroenterol. Jan 14, 2026; 32(2): 113810
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.113810
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.113810
Table 2 Residual tumor and local recurrence rates as a function of lesion size and treatment group, n (%)
| Residual tumor (n = 491 nodules) | Local tumor progression (n = 436 nodules) | |||
| Total | MWA (n = 168) | 21 (12.5) | MWA (n = 147) | 37 (25.2) |
| Mbp-RFA (n = 323) | 19 (5.9) | Mbp-RFA (n = 289) | 33 (11.4) | |
| P value | 0.01 | P value | 0.002 | |
| < 30 mm | MWA (n = 141) | 17 (12.1) | MWA (n = 124) | 23 (18.5) |
| Mbp-RFA (n = 227) | 15 (6.6) | Mbp-RFA (n = 201) | 17 (7) | |
| P value | 0.071 | P value | < 0.002 | |
| ≥ 30 mm | MWA (n = 27) | 4 (14.8) | MWA (n = 23) | 14 (60.9) |
| Mbp-RFA (n = 96) | 4 (4.2) | Mbp-RFA (n = 88) | 19 (21.6) | |
| P value | 0.069 | P value | 0.04 | |
- Citation: Bahloul C, Rode A, Pradat P, Milot L, Dumortier J, Merle P, Mabrut JY, Boussel L, Della Corte A. Multibipolar radiofrequency vs single needle microwave ablation for the treatment of newly diagnosed hepatocellular carcinoma. World J Gastroenterol 2026; 32(2): 113810
- URL: https://www.wjgnet.com/1007-9327/full/v32/i2/113810.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i2.113810